Precision BioSciences
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $638 | $576 | $49,898 | $17,584 |
Gross Profit | 638 | -434 | 48,516 | 16,157 |
EBITDA | -16,596 | -15,158 | 34,691 | 10,589 |
EBIT | -17,353 | -16,169 | 33,309 | 9,162 |
Net Income | -17,745 | -16,425 | 32,749 | 8,588 |
Net Change In Cash | 638 | 576 | 49,898 | 17,584 |
Free Cash Flow | -18,780 | -5,951 | -14,897 | -19,067 |
Cash | 85,899 | 98,752 | 123,571 | 137,766 |
Basic Shares | 7,085 | 7,287 | 7,011 | 5,063 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $68,696 | $48,727 | $25,098 | $115,529 |
Gross Profit | 68,696 | 40,472 | 16,094 | 115,529 |
EBITDA | 13,526 | -32,042 | -62,794 | -20,273 |
EBIT | 8,949 | -40,297 | -71,798 | -30,470 |
Net Income | 7,167 | -61,319 | -122,908 | -30,918 |
Net Change In Cash | 68,696 | 48,727 | 25,098 | 115,529 |
Cost of Revenue | 45,913 | 53,865 | ||
Free Cash Flow | -58,695 | -86,392 | -49,072 | -16,656 |
Cash | 85,899 | 116,678 | 189,576 | 143,663 |
Basic Shares | 6,883 | 3,841 | 2,929 | 1,956 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$2.13 |
2024-09-30 | -$2.25 |
2024-06-30 | $4.67 |
2024-03-31 | -$0.35 |
